dabigatran etexilate mesylate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
34 FDA-registered drug labelers
A-S Medication Solutions
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Alivus Life Sciences Limited
Apotex Corp.
Apotex Inc.
Ascend Laboratories, LLC
Aurobindo Pharma Limited
AvKARE
AvPAK
Biocon Limited
Boehringer Ingelheim Pharmaceuticals Inc.
Camber Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited
Dr.Reddys Laboratories Inc
Hetero Drugs Limited
HIKAL LIMITED
Jubilant Biosys limited
Major Pharmaceuticals
Medichem Manufacturing (Malta) Ltd.
METROCHEM API PRIVATE LIMITED
MSN Laboratories Private Limited
MSN Life Sciences Private Limited
Mylan Pharmaceuticals Inc.
Neuland Laboratories Limited
NorthStar RxLLC
Novadoz Pharmaceuticals LLC
Optimus Drugs Private Limited
Sichuan Qingmu Pharmaceutical Co., Ltd.
Srini Pharmaceuticals Private Limited
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teva API India Ltd
XLCare Pharmaceuticals, Inc.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Dabigatran
- •Dabigatran Etexilate
- •Pradaxa
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS872728-81-9
PubChem CID135566083
DTXSIDDTXSID20236248
FormulaC35H45N7O8S
Mol. Weight723.8 g/mol
SMILESCCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4.CS(=O)(=O)O
Data Sources
1355660832026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/dabigatran etexilate mesylate/cids/JSON
Archive: data/sources/pubchem_name/dabigatran etexilate mesylate.json
CAS 872728-81-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json